← FDA DRUG APPROVALS

FDA ANDA · ANDA202859

MONTELUKAST SODIUM

Sponsor: PHARMOBEDIENT

APPLICATION
ANDA202859
TYPE
ANDA
ORIGINAL APPROVAL
2014-10-30
LATEST ACTION
2015-12-08
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

MONTELUKAST SODIUMPrescription
MONTELUKAST SODIUM EQ 10MG BASE · TABLET · ORAL

Approval history

2015-12-08Labeling · Supplement 5 · standardAP
2015-06-25Manufacturing (CMC) · Supplement 2 · unknownAP
2015-03-20Labeling · Supplement 3 · standardAP
2015-03-20Labeling · Supplement 1 · standardAP
2015-03-20Labeling · Supplement 4 · standardAP
2014-10-30UNKNOWN · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →